Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults
- PMID: 35207209
- PMCID: PMC8878201
- DOI: 10.3390/jcm11040935
Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults
Abstract
Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome (MetS). However, the temporal relationship between NAFLD and MetS has yet to be evaluated, especially in young adults. In this study, we investigated whether NAFLD could be a precursor for MetS in metabolically healthy young adults. Using the Korean nationwide health screening database, we analyzed subjects aged 20-39 years who were free from any component of MetS between 2009 and 2012. A total of 1,659,192 subjects without excessive alcohol consumption or concomitant liver disease were categorized into three groups according to the fatty liver index (FLI): (1) NAFLD (FLI ≥ 60); (2) borderline NAFLD (30 ≤ FLI < 60); and (3) control (FLI < 30). During the 6,699,462 person-years of follow-up, 109,239 subjects developed MetS (16.3 per 1000-person-years). The NAFLD group and the borderline NAFLD group were associated with a higher risk of MetS than the control group (incidence rate ratios, 2.9 (95% confidence interval (CI), 2.7-3.1) for the NAFLD group and 2.1 (95% CI, 2.1-2.2) for the borderline NAFLD group, respectively). In addition, all of the metabolic components were positively associated with FLI in a proportional manner. NAFLD is associated with the future onset of MetS in young adults. Therefore, active lifestyle intervention is required for young adults diagnosed with NAFLD to prevent MetS and other metabolic diseases.
Keywords: fatty liver index; metabolic syndrome; nonalcoholic fatty liver disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Comment in
-
Von der Fettleber ist es nicht weit zum metabolischen Syndrom.MMW Fortschr Med. 2022 Oct;164(18):26-27. doi: 10.1007/s15006-022-1993-6. MMW Fortschr Med. 2022. PMID: 36253682 Review. German. No abstract available.
Similar articles
-
The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011.Diabetes Metab Syndr Obes. 2019 Jan 24;12:181-190. doi: 10.2147/DMSO.S189544. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 30774403 Free PMC article.
-
The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.Intern Emerg Med. 2025 Jan;20(1):105-117. doi: 10.1007/s11739-024-03758-6. Epub 2024 Sep 5. Intern Emerg Med. 2025. PMID: 39235708
-
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578. Medicine (Baltimore). 2016. PMID: 26817915 Free PMC article.
-
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24. Mol Cell Endocrinol. 2015. PMID: 25724480 Review.
-
Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2022 Jul 20;13:869579. doi: 10.3389/fendo.2022.869579. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937795 Free PMC article.
Cited by
-
Association between fatty liver disease and risk of microvascular complications in Type-2 diabetes mellitus: A systematic review and meta-analysis.Pak J Med Sci. 2025 Mar;41(3):902-909. doi: 10.12669/pjms.41.3.11362. Pak J Med Sci. 2025. PMID: 40103889 Free PMC article. Review.
-
The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome.Nutrients. 2023 Apr 27;15(9):2113. doi: 10.3390/nu15092113. Nutrients. 2023. PMID: 37432275 Free PMC article.
-
Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease.Diabetes Metab Syndr Obes. 2023 May 8;16:1323-1334. doi: 10.2147/DMSO.S408075. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37188227 Free PMC article.
-
Fatty liver index (FLI): more than a marker of hepatic steatosis.J Physiol Biochem. 2024 Feb;80(1):11-26. doi: 10.1007/s13105-023-00991-z. Epub 2023 Oct 25. J Physiol Biochem. 2024. PMID: 37875710 Review.
-
Prevalence and Risk Factors of Comorbid Obesity in Chinese Patients with Bipolar Disorder.Diabetes Metab Syndr Obes. 2023 May 18;16:1459-1469. doi: 10.2147/DMSO.S404127. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37229353 Free PMC article.
References
-
- Chan T.T., Tse Y.K., Lui R.N., Wong G.L., Chim A.M., Kong A.P., Woo J., Yeung D.K., Abrigo J.M., Chu W.C., et al. Fatty Pancreas Is Independently Associated with Subsequent Diabetes Mellitus Development: A 10-Year Prospective Cohort Study. Clin. Gastroenterol Hepatol. 2021. in press . - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources